Long-term efficacy and safety of ustekinumab in 122 refractory Crohn’s disease patients: a multicentre experience.

Wils P, Bouhnik Y, Michetti P, Flourie B, Brixi H, Bourrier A, Allez M, Duclos B, Serrero M, Buisson A, Amiot A, Fumery M, Roblin X, Peyrin-Biroulet L, Filippi J, Bouguen G, Abitbol V, Coffin B, Simon M, Laharie D, Pariente B

(Aliment Pharmacol Ther. 2018 Mar;47(5):588-595. – PMID: 29315694)

https://pubmed.ncbi.nlm.nih.gov/29315694/